Purpose The widespread use of abdominal imaging has affected the epidemiology of renal
cell carcinoma (RCC). Despite this, over 25% of individuals with RCC have evidence of …

Renal cell carcinoma (RCC) incidence has doubled over the past few decades. However,
death rates have remained stable as the number of incidental renal mass diagnoses …

Renal cell carcinoma (RCC) incidence is increasing worldwide. A high proportion of
individuals are asymptomatic at diagnosis, but RCC has a high mortality rate. These facts …

Context Early detection of kidney cancer improves survival; however, low prevalence means
that population-wide screening may be inefficient. Stratification of the population into risk …

Importance Microhematuria (MH) is a common finding that often leads to further evaluation
for urinary tract cancers. There is ongoing debate about the extent to which patients with MH …

For prostate cancer, we review racial differences in incidence, androgen pathways, growth
factors, tumor location, rate of definitive treatment, and outcomes. We review the effect of …

Introduction Kidney cancer (renal cell cancer (RCC)) is the seventh most common cancer in
the UK. As RCC is largely curable if detected at an early stage and most patients have no …

Purpose To systematically review studies focused on screening programs for renal cell
carcinoma (RCC) and provide an exhaustive overview on their clinical impact, potential …

Background Screening for renal cell carcinoma (RCC) has been identified as a key research
priority; however, no randomised control trials have been performed. Value of information …

Objectives To externally validate risk models for the detection of kidney cancer, as early
detection of kidney cancer improves survival and stratifying the population using risk models …